Salute e Benessere

Jazz Pharmaceuticals Announces Second Quarter 2024 Financial Results and Updates…

"Jazz's record revenues of over $1 billion in the second quarter were driven by strong execution and increased demand for our key growth drivers, Xywav, Epidiolex and Rylaze. Our launch preparations are well underway for zanidatamab, which was recently granted Priority Review in BTC, and we are pleased to have initiated the Phase 3 EmpowHER trial in HER2-positive breast cancer in patients whose disease has progressed after T-DXd treatment," said Bruce Cozadd, chairman and chief…
PR Newswire
31/07/2024

Inventiva Reports Preliminary 2024 First-Half Financial Information¹

Cash and cash equivalents at €10.1 million as of June 30, 2024, compared to cash and cash equivalents at €26.9 million, €0.01 2million of short-term deposits and €9.0 3million of long-term deposits as of December 31, 2023.On July 18, 2024, Inventiva issued royalty certificates subscribed by Samsara BioCapital and existing shareholders (BVF Partners, NEA, Sofinnova and Yiheng) for an amount of approximately €20.1 million.No Revenues recorded in H1 2024, compared to €1.9 million for the...
Nasdaq GlobeNewswire
31/07/2024

EUROBIO SCIENTIFIC: CONCLUSION OF AN AGREEMENT BETWEEN EUROBIO SCIENTIFIC AND A…

NOT FOR DISTRIBUTION, PUBLICATION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OR TO ANY US PERSON, OR TO ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION, PUBLICATION OR RELEASE WOULD BE UNLAWFUL. CONCLUSION OF AN AGREEMENT BETWEEN EUROBIO SCIENTIFIC AND A CONSORTIUM LED BY EUROBIO SCIENTIFIC'S TEAM OF ENTREPRENEURS AND MANAGERS, IK PARTNERS AND NEXTSTAGE AM WITH A VIEW TO FILE A VOLUNTARY TENDER OFFER AT A PRICE OF €25.30 PER EUROBIO SCIENTIFIC SHARE...
Nasdaq GlobeNewswire
31/07/2024

Eurobio Scientific: FIRST HALF 2024, A SOLID START TO THE FINANCIAL YEAR IN AN…

NOT FOR DISTRIBUTION, PUBLICATION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OR TO ANY US PERSON, OR TO ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION, PUBLICATION OR RELEASE WOULD BE UNLAWFUL. FIRST HALF 2024, A SOLID START TO THE FINANCIAL YEAR IN AN UNCERTAIN ENVIRONMENTPROPOSED TENDER OFFERHalf-year revenue growth of +24% (+12% excluding the effects of changes in the scope of consolidation linked to the acquisitions of DID and Alpha...
Nasdaq GlobeNewswire
31/07/2024

Medicilon and Hengrui Pharma Deepen Strategic Collaboration to Support…

The atmosphere of the exchange was enthusiastic and congenial. Hengrui Pharma's Vice General Manager & Global R&D President Lianshan Zhang, along with other executives, visited Medicilon's Pudong Chuansha Park. They were welcomed by Medicilon's CEO Chunlin Chen and key team members. The atmosphere of the exchange was enthusiastic and congenial. Hengrui Pharma's Vice General Manager & Global R&D President Lianshan Zhang, along with other executives, visited Medicilon's Pudong…
PR Newswire
31/07/2024

Liquid Biopsy Market: Rising Adoption to Propel 11.21% CAGR by 2031 | SkyQuest…

Furthermore, the increasing adoption of liquid biopsy signals an expansion in generalized medicine and cancer precision. These new diagnostic methods offer advantages over traditional biopsies analyzes body by real-time monitoring of disease progression and treatment response, providing timely intervention strategies such as early detection and prioritization. The liquid biopsy market is poised for further growth with advances in technology, expanded research efforts, driven by increased…
PR Newswire
31/07/2024

Molecular Diagnostic Market to Attain USD 37.00 Billion in 2031 As Genetic…

Download a detailed overview: Download a detailed overview: https://www.skyquestt.com/sample-request/molecular-diagnostics-market Molecular Diagnostics Market Overview: Segments covered in Molecular Diagnostics Market are as follows: Request Free Customization of this report: https://www.skyquestt.com/speak-with-analyst/molecular-diagnostics-market Molecular Diagnostics' Contribution to Personalized Medicine and Disease Detection Among the many goods and...
PR Newswire
31/07/2024

Advanced Wound Care Market to Reach USD 10.8 Billion by 2031, Driven by…

Download a detailed overview: Download a detailed overview: https://www.skyquestt.com/sample-request/advanced-wound-care-market Advanced Wound Care Market Overview: Segments covered in Advanced Wound Care Market are as follows: Request Free Customization of this report: https://www.skyquestt.com/speak-with-analyst/advanced-wound-care-market Rising Inclination towards Smart Wound Dressings to Accelerate Healing Process Supports Market Growth Smart dressings...
PR Newswire
31/07/2024

O'Ryan.Health Launches Groundbreaking Parent-Led Pediatric Studies Utilizing…

The institutional review board approved study involves healthy children and children with a JDM diagnosis. Capillary blood is drawn on a predetermined schedule using virtually painless TAP Micro devices. Guided by animated Superhero Scientists and comic book "mission reports" of their results, children take an active role in their healthcare journey and learn about their immune health. The institutional review board approved study involves healthy children and children with a JDM…
PR Newswire
31/07/2024

Visionet rebrands as a future-ready engineering partner

While its brand identity is evolving, its core values remain steadfast. Visionet continues to uphold problem-solving, agility, adaptability, and customer-centricity. Visionet is committed to delivering the high-quality products and services its customers have come to expect. While its brand identity is evolving, its core values remain steadfast. Visionet continues to uphold problem-solving, agility, adaptability, and customer-centricity. Visionet is committed to delivering the high-quality...
PR Newswire
31/07/2024

Essence SmartCare Integrates its Ultracompact Umbrella mPERS with North…

In the event of a medical emergency or safety threat, it is critical that monitoring services react in real-time, any time. Integrating Umbrella mPERS into their software allows these leading monitoring providers to sync all events and notifications with users so that in case of an emergency, providers can communicate directly with the user and first responders can be notified immediately. "Boosting Umbrella mPERS' availability throughout the country is a pivotal step forward in...
PR Newswire
31/07/2024

AC Immune Unveils Novel Therapeutic Antibody Drug Conjugate (ADC) Technology for…

AC Immune Unveils Novel Therapeutic Antibody Drug Conjugate (ADC) Technology for Improved Efficacy in Neurodegenerative Diseases at AAIC 2024 morADC combines proprietary brain-penetrant small molecule Morphomers ®with SupraAntigen ®monoclonal antibodies, forming a new class of drug-candidates to target toxic proteins in CNSmorADC demonstrated significant synergies, substantially increasing blood brain barrier penetration and potency to inhibit protein aggregation...
Nasdaq GlobeNewswire
31/07/2024

Theriva™ Biologics Receives Rare Pediatric Drug Designation by the U.S. FDA for…

“The FDA's decision to grant rare pediatric drug designation to VCN-01 highlights the urgent need for new treatment options for pediatric patients with retinoblastoma,” said Steven A. Shallcross, Chief Executive Officer of Theriva Biologics. “We are encouraged by this important step forward and, in parallel, continue to work closely with leading physicians and regulatory agencies to refine our clinical strategy for VCN-01 as an adjunct to chemotherapy in pediatric patients with advanced...
Nasdaq GlobeNewswire
31/07/2024

PROCESSED RED MEAT RAISES THE RISK OF DEMENTIA; SWAPPING IT FOR NUTS AND BEANS…

PHILADELPHIA, July 31, 2024 /PRNewswire/ -- People who eat at least 1/4 serving of bacon, bologna or other processed red meat a day (about two servings a week) have a higher risk of dementia than those who eat less than 1/10 of a serving a day (about three servings a month), according to a study reported today at the Alzheimer's Association International Conference® (AAIC®) 2024, in Philadelphia and online. PHILADELPHIA,July 31, 2024/PRNewswire/ -- People who eat at least 1/4 serving of...
PR Newswire
31/07/2024

Aily Labs Expands Global Footprint with New York Office Launch and Strengthens…

Jason Rizzo, joining as Senior Vice President of Sales, brings over 20 years of experience in B2B cloud software. With a proven track record in complex sales landscapes and strategic partnerships, Rizzo will be instrumental in expanding Aily Labs' global market reach and driving business growth. Previously, Rizzo served as Vice President of Global Life Science Strategy & Partnerships for InsightRX and led R&D and Quality for Veeva Systems. Jason Rizzo , joining as Senior Vice President…
PR Newswire
31/07/2024

Immatics Appoints Alise Reicin to Board of Directors

Houston, Texas and Tuebingen, Germany, July 31, 2024–Immatics N.V.(NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting cancer immunotherapies, today announced the appointment of Alise Reicin, M.D., to its Board of Directors. Alise Reicin is an experienced and expert pharmaceutical industry executive and leader who has led the development of multiple important new therapies, including...
Nasdaq GlobeNewswire
31/07/2024

Teva Announces Strong Growth in Second Quarter Revenues mainly driven by…

For an accessible version of this Press Release, please visit www.tevapharm.com Q2 2024 revenues of $4.2 billion reflecting an increase of 7% in U.S. dollars or 11% in local currency terms compared to Q2 2023.Generics business grows across all regions – increased in local currency terms by 16% in the U.S., 8% in Europe and 22% in International Markets, compared to Q2 2023.AUSTEDO – continued growth, U.S. revenue of $407 million in Q2 2024, an increase of 32% compared to Q2 2023;...
Nasdaq GlobeNewswire
31/07/2024

INDIAWOOD 2025: Quarter Century of Driving Innovation in Indian Woodworking and…

Since its inception in 2000, INDIAWOOD has grown exponentially, beginning at R.B.A.N.M.'s Grounds, transitioning to Palace Grounds, and finding its current home at the Bangalore International Exhibition Centre (BIEC) in 2008. The event has continually evolved, mirroring the dynamic nature of the industry. The upcoming edition will feature 600 exhibitors and is expected to attract over 30,000 visitors from across 1,200 cities, a remarkable increase from the 294 cities in 2002. Since its...
PR Newswire
31/07/2024

Pertussis Treatment Market Projected to Hit US$ 5.3 Billion by 2034, with a 3.4%…

Pertussis, also known as whooping cough, is an infectious respiratory disease caused by the Bordetella pertussis bacteria. Pertussis mostly affects young children and the older population, and treatment involves medication, vaccination, and supportive care. Pertussis, also known as whooping cough, is an infectious respiratory disease caused by the Bordetella pertussis bacteria. Pertussis mostly affects young children and the older population, and treatment involves medication, vaccination…
PR Newswire
31/07/2024

Kexing Biopharm's Albumin-bound Paclitaxel Granted EU Market Approval

In recent years, the Chinese pharmaceutical industry has embarked on a significant expansion into international markets. But actually, Kexing Biopharm began its international ventures 20 years ago with its core products. In recent years, the company has introduced more than a dozen high-quality Chinese medications to emerging markets, improving accessibility to medicines for local patients. In recent years, the Chinese pharmaceutical industry has embarked on a significant expansion into...
PR Newswire
31/07/2024

Furniture Market to Reach $840.5 Billion, Globally, by 2034 at 4% CAGR: Allied…

Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/5147 Download Sample Pages of Research Overview:https://www.alliedmarketresearch.com/request-sample/5147 Prime determinants of growth The growth of the furniture market is fueled by increased demand for residential and commercial furniture as populations migrate to cities. Rising disposable incomes enable consumers to invest in quality furniture, while changing lifestyle preferences...
PR Newswire
31/07/2024

Foresters Financial celebrates 150 years by donating to a member-selected…

Launched in 1977, the Tuberous Sclerosis Association (TSA) supports people living with TSC. This rare genetic disorder causes non-cancerous tumors in various organs, including the brain, skin, kidneys, heart, and lungs with symptoms varying from learning difficulties, seizures, and developmental delays. There is currently no cure, but treatment can manage symptoms and improve quality of life. Launched in 1977, the Tuberous Sclerosis Association (TSA) supports people living with TSC. This rare...
PR Newswire
31/07/2024

Essity spearheads menstrual health in partnership with the World Economic Forum

Essity's Chief Strategy Officer, Sahil Tesfu, has joined the Community of Champions of the Forum's Global Alliance for Women's Health. The Community of Champions is a collective of global leaders and advocates committed to prioritizing, protecting and promoting the health of women and closing the women's health gap. Essity's Chief Strategy Officer,Sahil Tesfu, has joined the Community of Champions of the Forum's Global Alliance for Women's Health. The Community of Champions is a collective...
PR Newswire
31/07/2024

Avance Clinical Announces Senior Appointment to North American Operations

Avance Clinical, an award-winning, mid-sized full-service global Contract Research Organization (CRO) for biotech companies, is pleased to announce the appointment of Jeanne Schow as Senior Vice President, Business Development. Jeanne will be based out of theSan Francisco Bay Area. Meet Jeanne Schow and the Avance Clinical North American team at the next biotech event.Book a Meeting Here.Yvonne Lungershausen, CEO of Avance Clinical, expressed her enthusiasm about Jeanne's...
Nasdaq GlobeNewswire
31/07/2024
Altri  Comunicati